We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Bill Would Address ‘Patent Thicket’ Critics Say Stymies Biosimilars
Senate Bill Would Address ‘Patent Thicket’ Critics Say Stymies Biosimilars
A bipartisan group of senators has introduced legislation that would address one of outgoing FDA Commissioner Scott Gottlieb’s pet peeves — the “patent thickets” preventing biosimilars from getting to market.